NAGJI BANSI
Known title: President, HealthcareCIK: 0001632311
Associated companies
Transaction History
| GDRX | ▲ Buy | Option Exercise | 16,300 | $111K | 10/20/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 16,300 | $734K | 10/20/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 100 | $684 | 10/19/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 100 | $5K | 10/19/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 3,600 | $25K | 10/7/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 3,600 | $162K | 10/7/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 29,788 | $204K | 9/16/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 29,788 | $1.3M | 9/16/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 60,415 | $413K | 9/15/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 60,415 | $2.7M | 9/15/2021 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 89,797 | $614K | 9/14/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 89,797 | $4.0M | 9/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.